Marcio Souza

Marcio Souza

President and Chief Executive OfficeratPraxis Precision Medicines· In proxies 2022–2025

Pay in FY2025-35% from the year before · Praxis Precision Medicines stock +283.0% the same year

Marcio Souza was paid $8.7M in FY2025 (Dec), down 35%. Praxis Precision Medicines stock rose 283.0% that year.

Pay$100 in the stock at the end of FY21 → $100
Pay is from the Summary Compensation Table of each Praxis Precision Medicines proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Praxis Precision MedicinesPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -3%
  2. Remagine LabsPublic company
    • Director? – PresentNo stock prices for these years
  3. Aeglea BioTherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Clearpoint Neuro, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. MRI Interventions, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Spyre Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?